Redox modulation of insulin signaling and endothelial function.
Reactive oxygen and nitrogen species (ROS and RNS) recently emerged as critical signaling molecules in cardiovascular research. Several studies over the past decade have shown that physiological effects of vasoactive factors are mediated by these reactive species and, conversely, that altered redox mechanisms are implicated in the occurrence of metabolic and cardiovascular diseases. Oxidant stress occurs when ROS and/or RNS production exceeds the cell natural antioxidant systems, and pathological events ensue. Cardiovascular risk factors are associated with an imbalance of the redox equilibrium toward oxidative stress, leading to endothelial activation and proinflammatory processes implicated in atherogenesis and metabolic disorders. Recent studies indicate that insulin and insulin-sensitizing drugs activate antiinflammatory pathways that may limit oxidant stress in insulin target tissues. The main goal of this brief review is to discuss recent progress in the field of cellular redox signaling as it pertains to insulin modulation of vascular endothelial function in cardiovascular diseases.
Lipides Membranaires et Fonctions Cardiovasculaires, UMR INRA-Université Paris XI, Faculté de Pharmacie, Châtenay-Malabry.
Raymond
R
Christon
Olivier
O
Drouin
Andre
A
Marette
D000818:Animals; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D015398:Signal Transduction
D005227:Fatty Acids; D007328:Insulin